BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03441360-completion@plaintrial.com
DTSTAMP:20261027T170430Z
DTSTART;VALUE=DATE:20220121
SUMMARY:Study to Assess Safety and Preliminary Activity of Eribulin Mesylat
 e in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS
 )\, Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EW
 S) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03441360
URL:https://plaintrial.com/trial/NCT03441360
END:VEVENT
END:VCALENDAR